Creganna-Tactx Appoints New Board Chairman

Scott R. Ward has been appointed as chairman of Galway, Ireland-based Creganna-Tactx Medical, a provider of medical device outsourcing services. Ward succeeds Ian Quinn, the company founder, who will continue as a non-executive director of the company’s board.
 
Ward brings years of medical device experience to the Greganna-Tactx table. He first joined the board in 2011. As former vice president and president of Medtronic Cardiovascular, he was responsible for the worldwide operations of the coronary, peripheral, endovascular and structural heart disease business units at the company.
 
“I look forward to working closely with the management and board to deliver the company’s next phase of growth,” Ward said. “Building on its current market leadership positions, the company is well placed to explore new avenues for development and expansion in a dynamic market environment.”
 
Helen Ryan, CEO of Creganna-Tactx Medical CEO added: “I would like to thank Mr. Quinn for his support over the past eight years and I look forward to working with Mr. Ward as our new Chairman. He brings a wealth of industry knowledge and experience which will be of great benefit to the Management team as we embark on a new phase in the development of the business.”
 
In addition to his appointment as chairman of the Creganna-Tactx Medical board, Ward is chairman to the board of MAP Pharmaceuticals Inc. and Gillette Children’s Specialty Healthcare and a member of the board of SurModics Inc. Ward holds a B.S. and an M.S. from the University of Minnesota.
 
Creganna-Tactx Medical specializes in technologies, products and services for minimally invasive device solutions.